Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses
Status: | Completed |
---|---|
Conditions: | Skin and Soft Tissue Infections |
Therapuetic Areas: | Dermatology / Plastic Surgery |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/8/2015 |
Start Date: | May 2011 |
End Date: | September 2014 |
This study expands upon pilot data for feasibility since May 2011. The study aims to
evaluate the effect of rapid test availability on use of targeted spectrum antibiotics for
non-MRSA abscesses in ambulatory patients in the Emergency Department (ED). The
multi-institutional study will assess the feasibility of providing the GeneXpert® MRSA/SA
SSTI assay to the ED and evaluate the impact of delivering the test result to clinicians in
real-time on patient management decisions regarding the use of antimicrobial agents.
Patients are randomized to standard culture (control arm) or to the GeneXpert® assay plus
standard culture.
evaluate the effect of rapid test availability on use of targeted spectrum antibiotics for
non-MRSA abscesses in ambulatory patients in the Emergency Department (ED). The
multi-institutional study will assess the feasibility of providing the GeneXpert® MRSA/SA
SSTI assay to the ED and evaluate the impact of delivering the test result to clinicians in
real-time on patient management decisions regarding the use of antimicrobial agents.
Patients are randomized to standard culture (control arm) or to the GeneXpert® assay plus
standard culture.
Inclusion Criteria:
- adults 18 years or older with community onset abscess
Exclusion Criteria:
- previous treatment for same abscess in past 14 days
- postoperative infection
- inability to provide informed consent
We found this trial at
2
sites
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
Click here to add this to my saved trials
Click here to add this to my saved trials